Seed VC · New York
ExSight invests in early-stage companies developing breakthrough technologies to aid, diagnose, and treat large populations afflicted with vision diseases, leveraging deep ophthalmic domain expertise from accomplished retinal surgeons to efficiently analyze early-stage risk and drive superior returns.
Business models
biotech_therapeutics, hardware, deeptech_ip, saas_b2b
Customer segments
Enterprise, Researchers, Healthcare providers
Geography
US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.
Exsight Ventures writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. Claude Fundraiser tracks Exsight Ventures alongside 45,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 45,000+ active investors in the database by fit. Exsight Ventures is one of them — and we'll tell you exactly where they sit in your top 100.